Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TSHA | SUPN | BHC | ||
| Company | Taysha Gene Therapies Inc | Supernus Pharm | Bausch Health Companies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 6.11 | 44.75 | 5.28 | ||
| High | 6.45 | 47.13 | 5.95 | ||
| Low | 6.10 | 44.75 | 4.71 | ||
| Latest | 6.34 | 46.84 | 4.76 | ||
| Change | +0.13 | +2.09 | -0.52 | ||
| % Change | +2.09% | +4.67% | -9.85% | ||
| Volume | 10,818,400 | 3,338,800 | 12,661,300 | ||
| 20-Day Average Volume | 3,505,000 | 774,785 | 2,885,140 | ||
| Previous Close | 6.21 | 44.75 | 5.28 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.96 | 44.74 | 5.04 | ||
| 20-Day Raw Stochastic | 60.11% | 93.40% | 14.13% | ||
| 20-Day Relative Strength | 54.70 | 51.46 | 41.46 | ||
| Weighted Alpha | +74.90 | +32.11 | -40.20 | ||
| Today's Opinion | 88% Buy | 72% Sell | 100% Sell | ||
| Previous Opinion | 88% Buy | 72% Sell | 88% Sell | ||
| Last Month's Opinion | 72% Buy | 56% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.25% since 06/18/26 | +5.54% since 06/18/26 | -0.21% since 06/18/26 | ||
| Low | 6.06 on 06/25/26 | 44.09 on 06/22/26 | 4.61 on 06/22/26 | ||
| High | 7.06 on 06/24/26 | 47.13 on 06/26/26 | 5.95 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +13.42% since 05/26/26 | -1.95% since 05/26/26 | -11.85% since 05/26/26 | ||
| Low | 5.26 on 06/09/26 | 42.45 on 06/16/26 | 4.57 on 06/18/26 | ||
| High | 7.06 on 06/24/26 | 48.38 on 05/27/26 | 5.95 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +46.76% since 03/26/26 | -7.79% since 03/26/26 | -7.03% since 03/26/26 | ||
| Low | 4.03 on 03/30/26 | 42.45 on 06/16/26 | 4.57 on 06/18/26 | ||
| High | 7.30 on 05/06/26 | 52.96 on 05/06/26 | 6.29 on 04/30/26 | ||
| 6-Month | |||||
| %Chg | +8.75% since 12/26/25 | -9.17% since 12/26/25 | -33.89% since 12/26/25 | ||
| Low | 4.03 on 03/30/26 | 42.45 on 06/16/26 | 4.57 on 06/18/26 | ||
| High | 7.30 on 05/06/26 | 59.68 on 02/25/26 | 8.00 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,821,869 | 2,718,594 | 1,780,354 | ||
| Shares Outstanding, K | 287,361 | 58,040 | 374,024 | ||
| Annual Sales | 9,770,000 | 718,950,000 | 10,266,000,000 | ||
| Annual Net Income | -109,000,000 | -38,550,000 | 157,000,000 | ||
| Last Quarter Sales | 5,490,000 | 207,710,000 | 2,524,000,000 | ||
| Last Quarter Net Income | -27,850,000 | -2,290,000 | -1,423,000,000 | ||
| 60-Month Beta | 1.19 | 0.55 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 05/06/26 | 0.59 on 05/05/26 | 0.78 on 04/29/26 | ||
| Earnings Date | 08/11/26 | 08/04/26 | 07/29/26 | ||
| Most Recent Dividend | N/A | N/A | 1.000 on 11/10/10 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.20 | 1.21 | ||